
FOSTER CITY, CA – Dec 3, 2020 – Dr. Michael Spinner, from Stanford University, Department of Medicine, Division of Oncology, will present at the 2020 Virtual ASH Annual Meeting an update to the recently published article in Blood Advances.
December 6, 2020

FOSTER CITY, CA and SEATTLE; Oct. 28, 2020 (Business Wire) – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, and All4Cure, which has built a real world data powered network of patients, clinicians and researchers to dramatically improve outcomes for millions of patients with cancer, today announced their partnership.
October 28, 2020

FOSTER CITY, CA – Oct. 13, 2020 – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Thomas A. Bock to its board of directors.
October 12, 2020

FOSTER CITY, CA – Sep. 24, 2020 – Notable, a functional precision medicine company, and myTomorrows, an integrated platform that links patients with an unmet medical need to treatments in development worldwide, are proud to announce their partnership.
September 24, 2020

FOSTER CITY, CA – Aug. 06, 2020 – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced a new precision oncology study with Washington University School of Medicine in St. Louis, exploring the feasibility of ex vivo drug screening to predict sensitivity and resistance to chemotherapy, and to identify novel synergies across a broad panel of anti-cancer therapies.
August 6, 2020

FOSTER CITY, CA – July 08, 2020 (GLOBE NEWSWIRE) – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today that Joseph Wagner, PhD, has joined the company as Chief Scientific Officer. Dr. Wagner.
July 8, 2020

FOSTER CITY, CA – June 23, 2020 (GLOBE NEWSWIRE) — Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today that the results of a Stanford study using its drug sensitivity screening platform have been published in Blood Advances (June 23, 2020; Volume 4, Issue 12).
June 23, 2020

FOSTER CITY, CA – April 30, 2020 — Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, announced a partnership today with the MDS Foundation. MDS Foundation (MDSF) provides insight and information to families on upcoming clinical trials for myelodysplastic syndrome (MDS). As part of the partnership, Notable […]
April 30, 2020

FOSTER CITY, CA – April 09, 2020 (GLOBE NEWSWIRE) — Notable, a technology leader redefining cancer treatment through rapid drug development via a clinically validated platform, announced today its board has appointed veteran life science executive Laurie Heilmann as Chief Executive Officer. She succeeds founder Matt De Silva who will remain a member of Notable’s […]
April 9, 2020

FOSTER CITY, CA – January 22, 2020 — Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, is launching its first self-sponsored clinical trial, designed from the ground up to help validate its cancer patient matching platform over the long term.
January 22, 2020
The 50 best workplaces for innovators
by fastcompany.com
Notable Named To Fast Company’s Inaugural List Of The 50 Best Workplaces for Innovators
by globenewswire.com
Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round
by genomeweb.com
Personalized cancer treatment startup Notable Labs nabs $40M Series B
by Kevin Truong
AI-focused Notable Labs score $40M in funding; Seattle Genetics/Astellas submit marketing application for enfortumab vedotin
by Natalie Grover
Notable raises $40 million to personalize cancer drug regimens
by Kyle Wiggers
Notable Labs lands $40M to expand AI-based cancer treatment tech
by Amirah Al Idrus
Notable Announces $40m Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology
July 16, 2019
Blood cancer startup targets treatment personalization
By Hannah Norman
Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer
By MedCity News
Notable Labs brings on 2 development executives ahead of its first blood cancer trials
By fiercebiotech.com
Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing NonProfit
By globenewswire.com
Notable Labs Collaborator at ASH Shows Company’s Platform Predicts Ex Vivo Drug Response in Myeloid Neoplasms
By globenewswire.com
The Leukemia & Lymphoma Society Presents Man & Woman of the Year
By mwoy.org
Tech investors take a Warren Buffett approach to raising money for blood cancer research
By cnbc.com May 19, 2018
In the next few weeks, you can spend time with any one of these VCs and it will all go to charity
By techcrunch.com on May 17, 2018
Here’s the Problem with Today’s Human Clinical Trials
By fortune.com on March 20, 2018
Builders VC Backs Personalized Cancer Treatment
By wsj.com on September 06, 2017
Notable Labs Raises $10M in Series A
By 360dx.com on September 06, 2017
Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists
By medcitynews.com on September 06, 2017
Notable Labs nets $10M for personalized cancer treatment tech
By fiercebiotech.com on September 06, 2017
Notable Labs Raises $10 Million Series A Financing to Advance Personalized Cancer Treatments
By businesswire.com on September 06, 2017
Laboratory Monitoring
By tetrascience.com on June 15, 2017
A High Throughput Screening System to Identify Actionable Treatments for Cancer Patients
By biosero.com on June 15, 2017
These seven researchers are changing the face of biotech
By bizjournals.com on June 8, 2017
Interview: Notable Labs tackles cancer research with cutting-edge tech
By tetrascience.com on June 12, 2017
ELITE Tech-Know Geek Transon Nguyen of Notable Labs
By pm360online.com on May 22, 2017
ELITE Disrupter Matthew De Silva of Notable Labs
By pm360online.com on May 22, 2017
The 2017 PM360 Elite 100
By pm360online.com on May 21, 2017
Labcyte Announces Collaboration with Notable Labs to Apply Functional Cancer Cell Screening
By labcyte.com on Dec 7, 2016
Robots Race for the Cure
By robotics.org on Nov 17, 2016
Notable Labs Enters into a Collaboration Agreement with IntelliCyt to Develop a Phenotypic Personalized
By intellicyt.com on Jun 20, 2016
Biden Comes To Silicon Valley For Innovation In White House Cancer Moonshot Initiative
By TechCrunch on Feb 27, 2016
Matthew De Silva
By Forbes on Jan 4, 2016
How Scientists Can Thrive in the Startup World
By themacro.com on Nov 18, 2015
YC Alum Atomwise Raises $6 Million To Further The Advancement Of Artificial Intelligence In Drug Dis
By TechCrunch on Jun 3, 2015
A Look Inside Transcriptic’s New Biotech Testing Facility
By TechCrunch on Mar 25, 2015
Y Combinator demo-thon: Check out 5 favorites from Day 2 – Silicon Valley Business Journal
By Boston Tech Flash on Mar 25, 2015
The Top 10 Startups Of Y Combinator Winter ’15 Demo Day 2
By TechCrunch on Mar 25, 2015
47 Startups That Launched At Y Combinator Winter 2015 Demo Day 2
By TechCrunch on Mar 24, 2015
Y Combinator backs cancer drug combo testing service
By fiercebiotechit.com on Mar 13, 2015
YC-Backed Notable Labs Provides Personalized Medical Testing For Brain Cancer Patients
By TechCrunch on Mar 10, 2015